ClinicalTrials.Veeva

Menu

Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging

Columbia University logo

Columbia University

Status

Completed

Conditions

Wheezing
Fever

Treatments

Behavioral: text message

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02295007
AAAO5253

Details and patient eligibility

About

Children 2-11 years of age who are given the influenza vaccine (inactivated influenza (IIV) or live attenuated influenza vaccine (LAIV)) as part of their routine care can enroll in this study if their parent has the ability to receive and send text messages. Children enrolled in this study will be observed daily for an eight-day period starting on the day of vaccine administration, and then continuing over the next 7 days, and then weekly for 42 days. On the day of enrollment and nightly for the next seven days, the parent will report via text message what their child's highest temperature is. If fever is present, they will then be prompted for additional information including other symptoms, antipyretic use and medical care sought. On day 3 as well as weekly from day 7 through day 42 post-vaccination, parents will be asked via text message about breathing problems, specifically cough, wheezing and chest tightness. They will also be asked about medications taken and care sought. The purpose of this study is to assess the feasibility of collecting this data.

Enrollment

266 patients

Sex

All

Ages

2 to 11 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. are 2 through 11years of age,
  2. have a visit at a study site anytime during the study period,
  3. receive first dose or second dose of LAIV4 or IIV in the season,
  4. the parent has a cell phone with text messaging capabilities, and
  5. the parent and child > 7 years of age speaks English or Spanish at the Columbia sites or English at the Boston site.

Exclusion criteria

  1. presence of fever ≥100.4 at time of vaccination,
  2. administration of any antipyretic in the 6-hour period prior to vaccination,
  3. stated intent, at time of vaccination, to use prophylactic antipyretics before the development of a fever,
  4. parent only speaks a language other than English or Spanish at the Columbia sites or English at the Boston site.
  5. enrollee is a child >7 years of age who only speaks a language other than English or Spanish at the Columbia sites or English at the Boston site.
  6. parent's inability to read and send text messages,
  7. sibling already enrolled this season (OR cell phone # already used for another child)
  8. chronic medical condition considered by ACIP to be a precaution or contraindication for LAIV1 (except for asthma),
  9. current asthma exacerbation, or exacerbation in the last 2 weeks
  10. use of oral or other systemic steroid within the last 2 weeks

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

266 participants in 1 patient group

text message
Other group
Description:
all families will receive text messages to which they can respond to report symptoms
Treatment:
Behavioral: text message

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems